Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Stonepine Capital Management, LLC
Form 13F · Q2 2026

Stonepine Capital Management, LLC

CIK 1440771Filed 2026-08-1713F-HR/A View the filing on EDGAR ↗
$177M
Reported book value
87
Positions
12
Quarters on record
Top 50
Positions

Stonepine Capital Management, LLC — holdings

Top 50 positions of 87, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1VSTM Verastem Inc3.3M+1.4%$13M7.2%
2EOLS Evolus Inc1.6M−9.6%$11M6.2%
3TENX Tenax Therapeutics Inc660,000−32.3%$10M5.4%
4NKTR Nektar Therapeutics120,654+41.9%$8M4.8%
5ADMA Adma Biologics Inc740,000+0.0%$6M3.5%
6CAMP Camp4 Therapeutics Corp1.4M+0.0%$6M3.4%
7ELOX Eloxx Pharmaceuticals Inc397,160—$6M3.1%
8KZIA Kazia Therapeutics Ltd345,179+0.0%$5M2.7%
9INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc100,000—$4M2.3%
10CRBP Corbus Pharmaceuticals Hldgs425,000+10.8%$4M2.2%
11MSLE Satellos Bioscience Inc491,624+391.6%$4M2.1%
12ZVRA Zevra Therapeutics Inc258,701−46.1%$4M2.1%
13ABEO Abeona Therapeutics Inc557,284−25.4%$3M1.9%
14EDSA Edesa Biotech Inc456,439+1421.5%$3M1.8%
15CABA Cabaletta Bio Inc917,100+1734.2%$3M1.6%
16ANTX An2 Therapeutics Inc551,692−22.7%$3M1.5%
17XLO Xilio Therapeutics Inc225,994+252.2%$2M1.2%
18ACET Adicet Bio Inc245,518+10.6%$2M1.2%
19TELA Tela Bio Inc2.7M+1.7%$2M1.1%
20AYTU Aytu Biopharma Inc912,921+15.2%$2M1.1%
21CRIS Curis Inc3.3M−11.1%$2M1.0%
22SPRB Spruce Biosciences Inc28,795—$2M0.9%
23OKYO Okyo Pharma Ltd862,996+1.5%$1M0.7%
24KTTA Pasithea Therapeutics Corp2.2M+164.8%$1M0.6%
25SLGL Sol-Gel Technologies Ltd14,469−47.9%$1M0.6%
26LUNG Pulmonx Corp815,436+6.1%$1M0.6%
27XFOR X4 Pharmaceuticals Inc224,989−32.9%$1M0.6%
28INAB In8Bio Inc695,287+4.8%$980,3550.6%
29MLTX Moonlake Immunotherapeutics50,000—$973,5000.5%
30QNRX Quoin Pharmaceuticals Ltd199,486+273.2%$965,5120.5%
31MXCT Maxcyte Inc751,606−25.2%$924,4750.5%
32PHAT Phathom Pharmaceuticals Inc85,010+70.0%$922,3580.5%
33AZTR Azitra Inc5.3M—$886,9030.5%
34CNTB Connect Biopharma Hldgs Ltd364,254+17.5%$866,9250.5%
35CYBIN INC Cybin Inc129,280−3.6%$854,5410.5%
36RARE Ultragenyx Pharmaceutical In25,000—$834,7500.5%
37IKT Inhibikase Therapeutics Inc396,179−58.6%$804,2430.5%
38ZNTL Zentalis Pharmaceuticals Inc161,583−40.0%$783,6780.4%
39CTMX Cytomx Therapeutics Inc.205,000+2.5%$768,7500.4%
40NVCT Nuvectis Pharma Inc40,000—$735,6000.4%
41CBIO Crescent Biopharma Inc.40,000−52.9%$720,0000.4%
42PMVP Pmv Pharmaceuticals Inc536,086−24.3%$718,3550.4%
43ORKA Oruka Therapeutics Inc7,500—$713,7750.4%
44RADX Radiopharm Theranostics Ltd51.0M+0.0%$670,5000.4%
45OKUR Onkure Therapeutics Inc130,684−1.4%$595,9190.3%
46NGEN Nervgen Pharma Corp271,678—$559,6570.3%
47CALC Calcimedica Inc622,432—$544,9390.3%
48ARVN Arvinas Inc60,000+118.2%$498,6000.3%
49BIOA Bioage Labs Inc20,000−60.0%$490,2000.3%
50IRD Opus Genetics Inc100,718+46.6%$413,9510.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.